Celebrating 20 years of innovation - Discover how we've been a catalyst for regional growth and UK innovation for over two decades in CPI's Annual Review 2023-2024.
Continuous direct compression could cut tablet production from weeks to days, putting life-saving medicines into patients’ hands faster. Here’s how.
Sept 04 2024
Blog
Failure is an option – if you learn from it
Innovation is risky, it might involve failure. But if we learn from it, innovation can pay off big time. Graeme shares his experience with failure.
Aug 14 2024
Blog
The next chapter in RNA-based medicine
What are RNA-therapeutics, and how will they revolutionise medicine? Julie Anderson answers these questions and tells us about CPI’s role in the industry.
Aug 07 2024
Blog
The future of pharma is here: How digital technologies are transforming drug development and manufacturing
The pharmaceutical industry is entering a new era of digitalisation, Industry 5.0. What shapes this new era? And what is CPI’s role in this shift?
Aug 01 2024
Blog
20 years of invigorating local communities
As we celebrate our 20th anniversary, we’re reflecting on two decades of incredible impact on multiple levels and across various communities.
Jul 25 2024
Blog
What is RNA and how is it used for therapeutics?
mRNA vaccines played a pivotal role during the COVID-19 pandemic. But what is RNA? And what other diseases can it cure? Louise Taylor tells us more.
Jul 23 2024
Blog
Future Food System 2050: What will it look like?
What innovations will feature in the future food system? How is the environmental crisis driving this transformation? How will we ensure a just transition?
Jul 18 2024
Blog
Big Concepts in Brief: What are Alternative Proteins?
Alternative proteins, in various forms, are already being consumed on a daily basis. What are alternative proteins? Kris Wadrop answers all.
Jul 17 2024
News
CPI publishes report calling for RNA skills development
The report, supported by FUJIFILM Diosynth Biotechnologies, highlights the need for a skilled UK taskforce to realise the potential of RNA technologies.
